Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $475,266 |
Sells | 124 | $9,441,166 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Jun 2023 17:40 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 08 Jun 2023 | Sale | 3,100 | 20.01 | 62,031 | I |
16 Jun 2023 16:48 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 14 Jun 2023 | Sale | 9,000 | 18.58 | 167,220 | I |
23 Jun 2023 16:29 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 21 Jun 2023 | Sale | 8,000 | 18.63 | 149,040 | I |
14 Jul 2023 16:40 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 12 Jul 2023 | Sale | 9,000 | 17.35 | 156,150 | I |
21 Jul 2023 17:42 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Jul 2023 | Sale | 99,726 | 20.04 | 1,998,509 | I |
21 Jul 2023 17:42 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Jul 2023 | Sale | 4,174 | 19.28 | 80,475 | I |
21 Jul 2023 17:46 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 19 Jul 2023 | Sale | 2,400 | 20.05 | 48,120 | D |
17 Aug 2023 18:02 | TARS | Tarsus Pharmaceuticals Inc | LIN ELIZABETH YEU | Director | 15 Aug 2023 | Purchase | 9,506 | 16.8 | 159,701 | I |
25 Aug 2023 17:12 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 23 Aug 2023 | Sale | 8,000 | 17.23 | 137,840 | I |
22 Sep 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Sep 2023 | Sale | 8,000 | 17.21 | 137,680 | I |
06 Oct 2023 17:21 | TARS | Tarsus Pharmaceuticals Inc | TREVEJO JOSE M. | CHIEF MEDICAL OFFICER | 05 Oct 2023 | Sale | 1,604 | 18 | 28,872 | D |
20 Oct 2023 16:41 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 18 Oct 2023 | Sale | 8,000 | 13.24 | 105,920 | I |
17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 200 | 19.28 | 3,856 | I |
17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 4,904 | 18.54 | 90,920 | I |
17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 2,896 | 18.01 | 52,157 | I |
01 Dec 2023 16:55 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 30 Nov 2023 | Sale | 8,356 | 16.31 | 136,286 | D |
01 Dec 2023 16:58 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 30 Nov 2023 | Sale | 8,355 | 16.31 | 136,270 | D |
19 Dec 2023 18:30 | TARS | Tarsus Pharmaceuticals Inc | GOLDBERG ANDREW D. | Director | 15 Dec 2023 | Purchase | 1,000 | 18.96 | 18,960 | D |
22 Dec 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Dec 2023 | Sale | 30,557 | 20.36 | 622,141 | I |
22 Dec 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Dec 2023 | Sale | 9,443 | 19.96 | 188,482 | I |
22 Dec 2023 17:32 | TARS | Tarsus Pharmaceuticals Inc | TREVEJO JOSE M. | CHIEF MEDICAL OFFICER | 20 Dec 2023 | Sale | 2,252 | 20 | 45,040 | D |
29 Dec 2023 17:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 27 Dec 2023 | Sale | 8,000 | 20.22 | 161,760 | I |
19 Mar 2024 19:03 | TARS | Tarsus Pharmaceuticals Inc | NEERVANNAN SESHADRI | Chief Operating Officer | 18 Mar 2024 | Sale | 4,879 | 30.6 | 149,297 | D |
19 Mar 2024 19:04 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 18 Mar 2024 | Sale | 4,314 | 30.6 | 132,008 | D |
19 Mar 2024 19:05 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 18 Mar 2024 | Sale | 10,415 | 30.6 | 318,699 | D |
19 Mar 2024 19:05 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 18 Mar 2024 | Sale | 4,436 | 30.6 | 135,742 | D |
19 Mar 2024 19:08 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 18 Mar 2024 | Sale | 4,766 | 30.6 | 145,840 | D |
20 Jun 2024 16:26 | TARS | Tarsus Pharmaceuticals Inc | FARROW JEFFREY S | See Remarks | 18 Jun 2024 | Sale | 10,445 | 27.47 | 286,924 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)